Vincerx Pharma Statistics Share Statistics Vincerx Pharma has 17.4M
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding 17.4M Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) n/a Shares Floating n/a Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 8.7K, so 0% of the outstanding
shares have been sold short.
Short Interest 8.7K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.92 and the forward
PE ratio is null.
Vincerx Pharma's PEG ratio is
0.06.
PE Ratio -0.92 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 10.11 P/FCF Ratio -1.05 PEG Ratio 0.06
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Vincerx Pharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.21,
with a Debt / Equity ratio of 0.
Current Ratio 1.21 Quick Ratio 1.21 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-716.05K Employee Count 42 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is 1.27, so Vincerx Pharma's
price volatility has been higher than the market average.
Beta 1.27 52-Week Price Change n/a 50-Day Moving Average n/a 200-Day Moving Average n/a Relative Strength Index (RSI) n/a Average Volume (20 Days) n/a
Income Statement
Revenue n/a Gross Profit n/a Operating Income -31.46M Net Income -30.07M EBITDA -31.46M EBIT n/a Earnings Per Share (EPS) -5.75
Full Income Statement Balance Sheet The company has 4.99M in cash and 0 in
debt, giving a net cash position of 4.99M.
Cash & Cash Equivalents 4.99M Total Debt n/a Net Cash n/a Retained Earnings -189.19M Total Assets n/a Working Capital n/a
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -26.13M
and capital expenditures 0, giving a free cash flow of -26.13M.
Operating Cash Flow -26.13M Capital Expenditures n/a Free Cash Flow -26.13M FCF Per Share -4.99
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
